Role of intra-accumbal cannabinoid CB1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference

Behavioural Brain Research

Volumn 247, Issue , 2013, Pages 125-131

  Karimi, Sara ^a   Azizi, Pegah ^b   Shamsizadeh, Ali ^a   Haghparast, Abbas ^b  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cannabinoid CB1 receptor; Conditioned place preference; Morphine; Nucleus accumbens; Rat; Reward

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 1 RECEPTOR ANTAGONIST; MORPHINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AVERSIVE BEHAVIOR; BRAIN REGION; CONDITIONING; CONTROLLED STUDY; LOCOMOTION; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; SCORING SYSTEM;

ANIMALS; BEHAVIOR, ANIMAL; BENZOXAZINES; CANNABINOIDS; CONDITIONING, OPERANT; MALE; MORPHINE; MORPHOLINES; MOTOR ACTIVITY; NAPHTHALENES; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; REWARD;

EID: 84876339439     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.03.022     Document Type: Article

References (47)

1. Jongen-Relo A.L., Voorn P., Groenewegen H.J. Immunohistochemical characterization of the shell and core territories of the nucleus accumbens in the rat. European Journal of Neuroscience 1994, 6:1255-1264.
2. Lee R.S., Criado J.R., Koob G.F., Henriksen S.J. Cellular responses of nucleus accumbens neurons to opiate-seeking behavior: I. Sustained responding during heroin self-administration. Synapse 1999, 33:49-58.
3. Martin M., Ledent C., Parmentier M., Maldonado R., Valverde O. Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. European Journal of Neuroscience 2000, 12:4038-4046.
4. Leshner A.I. Addiction is a brain disease, and it matters. Science 1997, 278:45-47.
5. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends in Pharmacological Sciences 1992, 13:177-184.
6. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Progress in Neurobiology 1998, 56:613-672.
7. Fattore L., Deiana S., Spano S.M., Cossu G., Fadda P., Scherma M., et al. Endocannabinoid system and opioid addiction: behavioural aspects. Pharmacology Biochemistry and Behavior 2005, 81:343-359.
8. Di Chiara G., North R.A. Neurobiology of opiate abuse. Trends in Pharmacological Sciences 1992, 13:185-193.
9. Karimi S., Karami M., Sahraei H., Rahimpour M. Reversal effect of intra-central amygdala microinjection of l-arginine on place aversion induced by naloxone in morphine conditioned rats. Iranian Biomedical Journal 2011, 15:92-99.
10. Gardner E.L. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacology Biochemistry and Behavior 2005, 81:263-284.
11. Solinas M., Goldberg S.R., Piomelli D. The endocannabinoid system in brain reward processes. British Journal of Pharmacology 2008, 154:369-383.
12. Fernandez-Ruiz J., Hernandez M., Ramos J.A. Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. CNS Neuroscience and Therapeutics 2010, 16:e72-e91.
13. French E.D. delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neuroscience Letters 1997, 226:159-162.
14. Gessa G.L., Melis M., Muntoni A.L., Diana M. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. European Journal of Pharmacology 1998, 341:39-44.
15. Tanda G., Pontieri F.E., Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 1997, 276:2048-2050.
16. Murray J.E., Bevins R.A. Cannabinoid conditioned reward and aversion: behavioral and neural processes. ACS Chemical Neuroscience 2010, 1:265-278.
17. Haghparast A., Azizi P., Hassanpour-Ezatti M., Khorrami H., Naderi N. Sub-chronic administration of AM251, CB1 receptor antagonist, within the nucleus accumbens induced sensitization to morphine in the rat. Neuroscience Letters 2009, 467:43-47.
18. Azizi P., Haghparast A., Hassanpour-Ezatti M. Effects of CB1 receptor antagonist within the nucleus accumbens on the acquisition and expression of morphine-induced conditioned place preference in morphine-sensitized rats. Behavioural Brain Research 2009, 197:119-124.
19. Braida D., Pozzi M., Cavallini R., Sala M. Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system. Neuroscience 2001, 104:923-926.
20. Navarro M., Carrera M.R., Fratta W., Valverde O., Cossu G., Fattore L., et al. Functional interaction between opioid and cannabinoid receptors in drug self-administration. Journal of Neuroscience 2001, 21:5344-5350.
21. Vigano D., Rubino T., Vaccani A., Bianchessi S., Marmorato P., Castiglioni C., et al. Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems. Psychopharmacology 2005, 182:527-536.
22. Lopez-Moreno J.A., Lopez-Jimenez A., Gorriti M.A., de Fonseca F.R. Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors. Current Drug Targets 2010, 11:406-428.
23. Jardinaud F., Roques B.P., Noble F. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice. Behavioural Brain Research 2006, 173:255-261.
24. Solinas M., Goldberg S.R. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats. Psychopharmacology 2005, 179:804-812.
25. Fattore L., Cossu G., Spano M.S., Deiana S., Fadda P., Scherma M., et al. Cannabinoids and reward: interactions with the opioid system. Critical Reviews in Neurobiology 2004, 16:147-158.
26. Singh M.E., Verty A.N., McGregor I.S., Mallet P.E. A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine. Brain Research 2004, 1026:244-253.
27. Justinova Z., Goldberg S.R., Heishman S.J., Tanda G. Self-administration of cannabinoids by experimental animals and human marijuana smokers. Pharmacology Biochemistry and Behavior 2005, 81:285-299.
28. Mahadevan A., Siegel C., Martin B.R., Abood M.E., Beletskaya I., Razdan R.K. Novel cannabinol probes for CB1 and CB2 cannabinoid receptors. Journal of Medicinal Chemistry 2000, 43:3778-3785.
29. Devane W.A. New dawn of cannabinoid pharmacology. Trends in Pharmacological Sciences 1994, 15:40-41.
30. Pontieri F.E., Monnazzi P., Scontrini A., Buttarelli F.R., Patacchioli F.R. Behavioral sensitization to heroin by cannabinoid pretreatment in the rat. European Journal of Pharmacology 2001, 421:R1-R3.
31. Vigano D., Valenti M., Cascio M.G., Di Marzo V., Parolaro D., Rubino T. Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine. European Journal of Neuroscience 2004, 20:1849-1857.
32. Robledo P., Berrendero F., Ozaita A., Maldonado R. Advances in the field of cannabinoid-opioid cross-talk. Addiction Biology 2008, 13:213-224.
33. Paxinos G., Watson C.R. The rat brain in stereotaxic coordinates 2007, Elsevier Academic Press, San Diego.
34. Haghparast A., Taslimi Z., Ramin M., Azizi P., Khodagholi F., Hassanpour-Ezatti M. Changes in phosphorylation of CREB, ERK, and c-fos induction in rat ventral tegmental area, hippocampus and prefrontal cortex after conditioned place preference induced by chemical stimulation of lateral hypothalamus. Behavioural Brain Research 2011, 220:112-118.
35. Kermani M., Azizi P., Haghparast A. The role of nitric oxide in the effects of cumin (Cuminum Cyminum L.) fruit essential oil on the acquisition of morphine-induced conditioned place preference in adult male mice. Chinese Journal of Integrative Medicine 2012, 1-6. 10.1007/s11655-011-0939-0.
36. Taslimi Z., Haghparast A., Hassanpour-Ezatti M., Safari M.S. Chemical stimulation of the lateral hypothalamus induces conditioned place preference in rats: involvement of OX1 and CB1 receptors in the ventral tegmental area. Behavioural Brain Research 2011, 217:41-46.
37. Olmstead M.C., Franklin K.B. The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites. Behavioral Neuroscience 1997, 111:1324-1334.
38. Rezayof A., Sardari M., Zarrindast M.R., Nayer-Nouri T. Functional interaction between morphine and central amygdala cannabinoid CB1 receptors in the acquisition and expression of conditioned place preference. Behavioural Brain Research 2011, 220:1-8.
39. Sahraei H., Zarei F., Eidi A., Oryan S., Shams J., Khoshbaten A., et al. The role of nitric oxide within the nucleus accumbens on the acquisition and expression of morphine-induced place preference in morphine sensitized rats. European Journal of Pharmacology 2007, 556:99-106.
40. Polissidis A., Galanopoulos A., Naxakis G., Papahatjis D., Papadopoulou-Daifoti Z., Antoniou K. The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently. International Journal of Neuropsychopharmacology 2012, 16:393-403.
41. Szabo B., Siemes S., Wallmichrath I. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. European Journal of Neuroscience 2002, 15:2057-2061.
42. Cossu G., Ledent C., Fattore L., Imperato A., Bohme G.A., Parmentier M., et al. Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behavioural Brain Research 2001, 118:61-65.
43. Rodriguez J.J., Mackie K., Pickel V.M. Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. Journal of Neuroscience 2001, 21:823-833.
44. Pickel V.M., Chan J., Kash T.L., Rodriguez J.J., MacKie K. Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience 2004, 127:101-112.
45. Chen B.T., Hopf F.W., Bonci A. Synaptic plasticity in the mesolimbic system: therapeutic implications for substance abuse. Annals of the New York Academy of Sciences 2010, 1187:129-139.
46. Vigano D., Rubino T., Parolaro D. Molecular and cellular basis of cannabinoid and opioid interactions. Pharmacology Biochemistry and Behavior 2005, 81:360-368.
47. Mascia M.S., Obinu M.C., Ledent C., Parmentier M., Bohme G.A., Imperato A., et al. Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice. European Journal of Pharmacology 1999, 383:R1-R2.